Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study.

Rosati, Alberto; Conti, Paolo; Berto, Patrizia; Molinaro, Sabrina; Baldini, Federica; Egan, Colin Gerard; Panichi, Vincenzo

Rosati, Alberto; Conti, Paolo; Berto, Patrizia; Molinaro, Sabrina; Baldini, Federica; Egan, Colin Gerard; Panichi, Vincenzo.

Afiliación

Rosati A; SOC Nefrologia e Dialisi, Ospedale San Giovanni di Dio, 50143 Firenze, Italy.
Conti P; Nephrology and Dialysis Unit, Nephrology Department, Arezzo Hospital, 52100 Arezzo, Italy.
Berto P; Regulatory Pharma Net S.r.L., 56125 Pisa, Italy.
Molinaro S; National Research Council, Institute of Clinical Physiology (CNR-IFC), 56124 Pisa, Italy.
Baldini F; National Research Council, Institute of Clinical Physiology (CNR-IFC), 56124 Pisa, Italy.
Egan CG; CE Medical Writing S.r.L.S., 56021 Pisa, Italy.
Panichi V; Nephrology and Dialysis Unit, Versilia Hospital, 55049 Lido Di Camaiore, Italy.

J Clin Med ; 11(18)2022 Sep 07.

Article en En | MEDLINE | ID: mdl-36142929

Palabras clave

chronic kidney disease; ferric carboxymaltose; hemodialysis; hemoglobin; intravenous iron supplementation; iron deficiency anemia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google